Droplet Digital PCR detects and quantifies cancer mutation
Two ddPCR-based assays were developed to detect the two mutations in the promoter region of the TERT gene, which could be used as biomarkers...
List view / Grid view
Two ddPCR-based assays were developed to detect the two mutations in the promoter region of the TERT gene, which could be used as biomarkers...
16 August 2016 | By Niamh Louise Marriott, Digital Content Producer
The drug development company will collaborate with the research centre on develoing microbiome-derived immunotherapies for cancer patients, to influence the efficacy of checkpoint inhibitors...
25 April 2016 | By Victoria White, Digital Content Producer
A study shows that most aggressive form of pancreatic cancer thrives in the presence of neighbouring tumour cells undergoing a particular form of cell death...